此次降级反映了Jones Trading的评估，即Anavex当前的股票价值完全取决于欧洲药品管理局 (EMA)即将对阿尔茨海默病药物blarcamesine做出的决定。该申请于2024年12月被接受，人用药品委员会 (CHMP)的意见预计将在2025年11月或12月公布。根据 InvestingPro 分析，该股票目前以8.6倍的市净率交易，相对于其公允价值而言被高估。

Explore top MACD strategies to identify trading entry and exit points. Learn how MACD indicators help predict market momentum ...

USD/CAD extends its gains for the second successive session, trading around 1.3990 during the early European hours on Friday.

Discover the latest bearish signals for Bitcoin and the crypto market. Learn why waiting for a pullback may offer better buy ...

The three US indices covered here all look a bit sluggish in the premarket trading session, as we are struggling to find some ...

Slips Below 200-Day EMA (Chart). <li /> The British pound initially rallied on Tuesday but reversed sharply, falling below ...

The USD/CAD pair trades marginally higher to near 1.4000 during the European trading session on Tuesday. The Loonie pair ticks up even as the US Dollar (USD) faces selling pressure, indicating ...

The US dollar continues to strengthen overall in the early hours of Thursday trading. At this point in time, the greenback ...

USDCHFgained sharply on board-based US dollar buying. Currently trading at 0.80340, it reached an intraday high of 0.80489.

SOL rebounds above $192 with rising trading volume and Optimism ahead of Accelerate APAC event. Technical indicators point to ...